HilleVax, Inc.
HilleVax, Inc. (HLVX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
hlvx · stock forecast · 6 analysts (3M) · FMP · updated Feb 3, 2026
Analyst Rating & Consensus
Based on 6 Wall Street analysts in the past 3 months
Hold
6 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$34.00
Consensus
$32.00
+1431.1% upside
Low
$30.00
Median: $32 · Last Close: $2.09
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Short-Term Price Prediction
Low ActivityAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $2.09 | ↓ 0.04% |
1-day model range: $2.08–$2.1. Peak: $2.1 (-0.04%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | — | +5.3% |
| 2028 | — | +8.1% |
| 2029 | — | +9.5% |
| 2030 | — | +10.2% |
| 2031 | — | +10.6% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Insufficient Trading Activity — Sentiment Signals Disabled
This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.
Moving Averages · HLVX · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-03-31 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2024-08-12 | HC Wainwright & Co. | Maintains | Neutral→Neutral |
| 2024-07-09 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2024-07-09 | Leerink Partners | Downgrade ↓ | Outperform→Market Perform |
| 2024-07-09 | Stifel | Downgrade ↓ | Buy→Hold |
| 2024-07-08 | Guggenheim | Downgrade ↓ | Buy→Neutral |
| 2024-07-08 | JP Morgan | Downgrade ↓ | Overweight→Neutral |
| 2024-05-15 | JP Morgan | Maintains | Overweight→Overweight |
| 2024-05-10 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-03-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on HilleVax, Inc. (HLVX) stock. Of the recent 17 rating actions, 0 were upgrades and 5 were downgrades. 6 analysts currently cover HLVX.
Analyst Recommendation Trends
HLVX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$0M
↓ 100.0% YoY
Revenue Next Year
$3M
EPS This Year
$-0.49
EPS Next Year
$-0.46
↓ 6.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast HLVX EPS of $-0.49 for the current fiscal year, based on estimates from 1 analysts. The HLVX revenue forecast is $0M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The HLVX stock forecast is supported by two independent data sources: analyst consensus ratings from 6 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus HLVX price target is $32.00 (+1431.1% upside), with an analyst consensus of Hold.
The HLVX short-term stock prediction for tomorrow is $2.09 (-0.04%). The HLVX stock prediction for 2030 projects a range of $2–$2.
HilleVax, Inc. trades on NASDAQ under the ticker HLVX. The HLVX stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 17% of covering analysts.
Frequently asked questions
HLVX forecast · 8 questionsAccording to 6 Wall Street analysts, the average 12-month HLVX price target is $32.00, with a high forecast of $34.00 and a low of $30.00. The median price target is shown in the chart above when available. This implies +1431.1% potential upside from the current price of $2.09.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.